Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496158 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
A Phase 3 study, sponsored by Pharmasset.
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00496158: Clinical Trial Phase 3 study, sponsored by Pharmasset.
NCT00496158 is a Phase 3 study that was terminated before completion, run by Pharmasset. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00496158, a Phase 3 study, was terminated before completion, sponsored by Pharmasset.
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
The objectives of this study are to compare in nucleoside treatment-naïve subjects, the efficacy and safety of clevudine 30 mg once daily versus adefovir 10 mg once daily, each as monotherapy, for 48 weeks, 72 weeks, and 96 weeks.
Interventions
- DRUG Adefovir
- DRUG Clevudine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-08 |
| Phase | Phase 3 |
Why NCT00496158 stopped before completion
NCT00496158 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Adefovir is the first listed.
NCT00496158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00496158 about?
NCT00496158 is a clinical study titled "Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus". The objectives of this study are to compare in nucleoside treatment-naïve subjects, the efficacy and safety of clevudine 30 mg once daily versus adefovir 10 mg once daily, each as monotherapy, for 48 weeks, 72 weeks, and 96 weeks.
What is the current status of trial NCT00496158?
This trial is currently terminated. It is a Phase 3 study. The study started on 2007-08.
What interventions are being tested in trial NCT00496158?
The interventions under investigation include: Adefovir (DRUG), Clevudine (DRUG).
Who is sponsoring clinical trial NCT00496158?
This trial is sponsored by Pharmasset, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia